aducanumab: the controversy over its accelerated approval for alzheimer’s disease
Published 2 years ago • 863 plays • Length 41:17Download video MP4
Download video MP3
Similar videos
-
5:38
controversy over newly approved alzheimer's drug
-
8:39
what is the controversy over aducanumab/aduhelm for alzheimer's?
-
29:47
the alzheimer’s treatment controversy: implications of accelerated drug approvals
-
2:56:46
aducanumab virtual symposium at johns hopkins university
-
5:55
controversy around fda’s approval of biogen alzheimer’s drug, aducanumab
-
29:18
the alzheimer’s treatment controversy: implications of accelerated drug approvals
-
0:59
the fda has approved aducanumab (aduhelm™). now what?
-
2:03
effectiveness of aducanumab treatment in alzheimer’s disease
-
1:25:31
lecanemab for treatment of early alzheimer’s disease: overview & clinician perspectives
-
5:59
aduhelm is fda approved for alzheimer's, but does it work?
-
0:50
approval of aducanumab for alzheimer’s disease
-
5:13
aducanumab,biogen aduhelm,fda approval for alzheimer disease
-
2:23
experts responds to fda approval of aducanumab | being patient
-
58:38
implications of aducanumab, the new alzheimer's drug with gil rabinovici and rita redberg
-
55:24
understanding the aducanumab (aduhelm) approval in the us
-
7:19
new alzheimer's drug aducanumab approved in the us is dividing doctors and patients | 7.30
-
0:55
approval of aducanumab for alzheimer’s disease
-
8:40
a new alzheimer's drug brings hope, controversy
-
0:16
more time | alzheimer’s association